Related Experiment Video
Updated: Jul 18, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Early-life gut microbiota and neurodevelopment in preterm infants: a narrative review
Isadora Beghetti1,2, Monica Barone3, Patrizia Brigidi3
1Neonatal Intensive Care Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Insights
Preterm infants
Area of Science:
- Microbiology
- Neuroscience
- Developmental Pediatrics
Background:
- Preterm infants face high risks of gut microbiota (GM) dysbiosis and neurodevelopmental issues.
- Early GM dysbiosis impacts short-term outcomes, with growing interest in its long-term effects on infant health.
- The early life periods for GM and nervous system development significantly overlap.
Purpose of the Study:
- To review the developing GM in early life and its relationship with neurodevelopment in preterm infants.
- To synthesize evidence from animal models and human studies on the GM-neurodevelopment connection.
- To highlight potential biomarkers and therapeutic targets for neurodevelopment in this vulnerable population.
Main Methods:
- Narrative review of existing literature.
- Analysis of findings from animal models on GM-brain development pathways.
- Examination of studies linking GM patterns in preterm infants to brain maturation and neurodevelopmental outcomes.
Main Results:
- Animal models show pathways linking early GM to brain development.
- GM patterns (dynamic and static) in preterm infants correlate with brain maturation.
- GM features in early life are associated with neurodevelopmental outcomes in early childhood.
Conclusions:
- The gut microbiota plays a crucial role in the neurodevelopment of preterm infants.
- Further research integrating human and animal studies is needed to identify predictive biomarkers and therapeutic targets.
- Understanding the GM-brain axis is vital for improving long-term health outcomes in preterm infants.
Abstract:
Infants born preterm are at a high risk of both gut microbiota (GM) dysbiosis and neurodevelopmental impairment. While the link between early dysbiosis and short-term clinical outcomes is well established, the relationship with long-term infant health has only recently gained interest. Notably, there is a significant overlap in the developmental windows of GM and the nervous system in early life. The connection between GM and neurodevelopment was first described in animal models, but over the last decade a growing body of research has also identified GM features as one of the potential mediators for human neurodevelopmental and neuropsychiatric disorders. In this narrative review, we provide an overview of the developing GM in early life and its prospective relationship with neurodevelopment, with a focus on preterm infants. Animal models have provided evidence for emerging pathways linking early-life GM with brain development. Furthermore, a relationship between both dynamic patterns and static features of the GM during preterm infants' early life and brain maturation, as well as neurodevelopmental outcomes in early childhood, was documented. Future human studies in larger cohorts, integrated with studies on animal models, may provide additional evidence and help to identify predictive biomarkers and potential therapeutic targets for healthy neurodevelopment in preterm infants.
More Related Videos
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015